1. Australia Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Curvebeam AI Ltd.

Curvebeam AI Ltd.

AASX:CVB
0.02
AUD
+0.00
(+5.00%)
-0.08EPS
50.84MMarket Cap
Mar 04Next Earn
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
- -
0.01
0.01
0.2
0.26
0.35
0.29
0.3
0.02
0.02
0.13
0.02
- -
Basic EPS, GAAP
-0.09
-0.08
-0.02
0.03
- -
0.01
-0.05
0.01
-0.02
-0.03
-0.85
-0.08
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.09
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.02
0.09
0.22
0.3
0.29
0.29
0.23
0.23
- -
- -
-0.69
0.12
- -
Tangible Book Value per Share
0.02
0.09
0.22
0.02
-0.05
-0.02
- -
- -
- -
- -
-1.28
- -
- -
Basic Weighted Avg Shares
50
5
9
47
77
85
99
100
331
331
60
294
375
Sales/Revenue/Turnover
- -
- -
- -
9
20
30
29
30
7
7
8
7
- -
Operating Margin (%)
-2,074.04
-841.97
-420.44
-0.19
1.75
2.55
0.1
4.27
-105.92
-161.61
-232.85
-366.76
- -
Depreciation Expense
- -
- -
- -
1
- -
1
- -
- -
- -
- -
2
3
- -
Net Income, GAAP
-4
- -
- -
2
- -
1
-5
1
-7
-10
-51
-23
- -
Effective Tax Rate (%)
- -
- -
- -
100
28.03
8.57
- -
14.92
- -
- -
- -
- -
- -
Profit Margin (%)
-3,481.15
-780.27
-338.18
16.43
1.81
3.13
-16.55
3.23
-93.73
-129.66
-635.95
-353.94
- -
Working Capital
1
- -
2
3
-1
1
4
4
- -
- -
-19
15
- -
LT Debt
- -
- -
- -
2
4
5
6
6
- -
- -
13
15
- -
Total Equity
1
- -
2
23
24
26
23
23
- -
- -
-48
39
- -
Return on Invested Capital (%)
- -
- -
- -
- -
0.89
2.2
- -
3.38
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
10.9
2.34
4.7
- -
5.07
- -
- -
- -
- -
- -
Return on Common Equity (%)
-83.12
-58.96
-17.54
12.5
1.56
3.75
-19.93
4.28
-58.56
- -
- -
- -
- -

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
8
2024
- -
- -
7
2025
- -
- -
- -

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.85
2024
- -
- -
-0.08
2025
- -
- -
- -

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Gregory Wayne Brown
Sector
Health technology
Industry
Biotechnology
Address
2800 Bronze Drive Melbourne PA Australia 19440
IPO Date
Aug 21, 2023
Website
curvebeamai.com
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. It operates through the following geographical segments: North America, Europe, and Rest of World. The company was founded in September 2022 and is headquartered in Melbourne, Australia.